Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1994 2
1996 1
2001 3
2003 2
2004 1
2006 4
2007 4
2008 1
2009 1
2010 3
2011 2
2012 3
2013 4
2014 7
2015 7
2016 5
2017 7
2018 6
2019 4
2020 5
2021 7
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Kazarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Shire N, Jiang H, Goldman JW; CASPIAN investigators. Paz-Ares L, et al. Lancet. 2019 Nov 23;394(10212):1929-1939. doi: 10.1016/S0140-6736(19)32222-6. Epub 2019 Oct 4. Lancet. 2019. PMID: 31590988 Clinical Trial.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Goldman JW, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Garassino MC, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Każarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Thiyagarajah P, Jiang H, Paz-Ares L; CASPIAN investigators. Goldman JW, et al. Lancet Oncol. 2021 Jan;22(1):51-65. doi: 10.1016/S1470-2045(20)30539-8. Epub 2020 Dec 4. Lancet Oncol. 2021. PMID: 33285097 Clinical Trial.
Lung cancer.
Skřičková J, Kadlec B, Venclíček O, Merta Z. Skřičková J, et al. Cas Lek Cesk. 2018 Fall;157(5):226-236. Cas Lek Cesk. 2018. PMID: 30441934 English.
[Nosocomial pneumonia].
Skřičková J. Skřičková J. Vnitr Lek. 2017 Fall;63(7-8):518-526. Vnitr Lek. 2017. PMID: 28933178 Czech.
[Pancreaticopleural fistula].
Skricková J. Skricková J. Vnitr Lek. 2007 Feb;53(2):111. Vnitr Lek. 2007. PMID: 17419169 Czech. No abstract available.
[Non-small cell lung cancer].
Skřičková J, Kadlec B, Venclíček O. Skřičková J, et al. Vnitr Lek. 2018 Winter;63(11):861-874. Vnitr Lek. 2018. PMID: 29303290 Review. Czech.
Lung cancer - dia nosis and early detection.
Skřičková J, Nebeský T, Kadlec B, Hejduk K, Májek O, Vašáková M, Čierná Peterová I. Skřičková J, et al. Klin Onkol. 2021 Spring;34(Supplementum 1):6-19. doi: 10.48095/ccko2021S6. Klin Onkol. 2021. PMID: 34154325 Review. English.
[Radiotherapy of Lung Tumours in Idiopathic Pulmonary Fibrosis].
Kolek V, Vašáková M, Šterclová M, Cwiertka K, Vrána D, Kudláček A, Skřičková J, Pešek M, Petera J. Kolek V, et al. Among authors: skrickova j. Klin Onkol. 2017 Summer;30(4):303-306. doi: 10.14735/amko2017303. Klin Onkol. 2017. PMID: 28832178 Review. Czech.
Therapy of small cell lung cancer with emphasis on oral topotecan.
Pirker R, Berzinec P, Brincat S, Kasan P, Ostoros G, Pesek M, Plāte S, Purkalne G, Rooneem R, Skricková J, Stanculeanu D, Timcheva C, Tzekova V, Zakotnik B, Zielinski CC, Zwitter M. Pirker R, et al. Among authors: skrickova j. Lung Cancer. 2010 Oct;70(1):7-13. doi: 10.1016/j.lungcan.2010.05.020. Epub 2010 Jun 23. Lung Cancer. 2010. PMID: 20576312 Review.
81 results